Well guys.... the new website for Nyrada Inc is now up and running and what better page to start with than the Q&A section
http://www.nyrada.com/site/nyrada-inc-q-and-a/investor-q-and-a
There’s a lot of info on the site but probably the most interesting item for Noxopharm shareholders is that with your NOX holding you effectively get a share in Nyrada for free with no further investment needed.
A really great bonus.
The only problem that I can see is..... we won’t be able to have a separate discussion board for it on HC. Still... no great hardship to incorporate our discussion and undoubted interest here on the NOX board for the time being.
Q&A section part below for your interest.
Another great addition to follow in the coming months... and I am in awe at how quickly GK moves and gets projects up and running. A masterclass in innovation and collaboration.
Apples
Investor Q and A
Investor Questions and Answers about Nyrada Inc.
Q: Is Noxopharm moving to the USA?
A: No. Nyrada Inc. is a fully independent, separate company which will eventually reside in the USA.
Q: How will Noxopharm shareholders benefit from Nyrada Inc.?
A: Noxopharm will be a major shareholder in Nyrada Inc. which will hold all the non-oncology projects, including those spun out of Noxopharm. Nox shareholders will be major beneficiaries of any upside value of Nyrada Inc. As a result, it is expected the value of Noxopharm is being added to, for the benefit of its shareholders.
Q: Will Noxopharm fund Nyrada Inc.?
A: No. Nyrada Inc. will be separately capitalised and have its own Board of Directors and Management team. There will be no dilution of Noxopharm shares.
Q: Who will be on the Board of Directors of Nyrada Inc.?
A: Board of 3 Directors expected for next 12 months.
- Graham Kelly - Executive Chairman and President.
- 2 non-executive directors ( to be announced).
Q: When will Nyrada Inc. move to the USA?
A: It is envisaged in the next 12-18 months. Further pre-clinical research to continue in Australia.
Q: How many staff and scientists?
A: Projected 6 scientists (2x per asset), CSO and Vice President US Operations (appointed) for next 12-18 months.
Add to My Watchlist
What is My Watchlist?
